ISO 9001:2015 | WHO-GMP Certified

Topical Preparations (Ointments, Creams & Gels)

High-quality therapeutic ointments, creams, and gels for optimal care.

Creams
Dermatological

ACYCLOMON 5gm

ACYCLOMON packaging

Acyclovir IP 5% w/w, Cream base q.s.

  • Composition: Acyclovir IP 5% w/w, Cream base q.s....
  • Packaging: 5gm
  • Approved Use: Topical Application

Dermatological

Beclomethasone Dipropionate Cream 15gm

Beclomethasone Dipropionate Cream packaging

Hydrophilic Base.. Q.S. Neomycin Sulphate IP Eq. To Neomycin - 0.5% * w / w Preservative Chlorocresol IP 0.1% * w / w Cream Base.. Q.S.

  • Composition: Hydrophilic Base.. Q.S. Neomycin Sulphate IP Eq. To Neomycin - 0.5% * w / w Preservative Chlorocres...
  • Packaging: 15gm
  • Approved Use: Topical Application

Dermatological

BECLOMON-C 15gm

BECLOMON-C packaging

Clotrimazole IP 1% w/w cream Base.. Q.S.

  • Composition: Clotrimazole IP 1% w/w cream Base.. Q.S....
  • Packaging: 15gm
  • Approved Use: Topical Application

Dermatological

BETMON 15gm

BETMON packaging

Mupirocin IP 2% w/w Water Soluble Ointment base .....… Q.S Boils Carbuncles

  • Composition: Mupirocin IP 2% w/w Water Soluble Ointment base .....… Q.S Boi...
  • Packaging: 15gm
  • Approved Use: Topical Application

Dermatological

Bifonazole cream IP 1% w/w 15gm

Bifonazole cream IP 1% w/w packaging

Preservative Benzyl Alcohol - 2% w/w In cream Base... q.s.

  • Composition: Preservative Benzyl Alcohol - 2% w/w In cream Base... q.s....
  • Packaging: 15gm
  • Approved Use: Topical Application

Dermatological

CLOBETAMON 15gm

CLOBETAMON packaging

Clobetasol Propionate IP 0.05% w/w Miconazole Nitrate IP 2.0% w/w Gentamicin Sulphate IP Eq. to Gentamicin 0.1% w/w Cream Base q. s. Clobetasol Propionate, Miconazole

  • Composition: Clobetasol Propionate IP 0.05% w/w Miconazole Nitrate IP 2.0% w/w Gentamicin ...
  • Packaging: 15gm
  • Approved Use: Topical Application

Dermatological

DERMON 15gm

DERMON packaging

Silver Sulphadiazine IP 1.0% w/w Methylparaben IP 0.165% w/w Propylparaben IP 0.077% w/w (As Preservative) Cream Base. Q.S. FOR EXTERNAL USE ONLY

  • Composition: Silver Sulphadiazine IP 1.0% w/w Methylparaben IP 0....
  • Packaging: 15gm
  • Approved Use: Topical Application

Dermatological

Desonide Cream USP 0.05% w/w 15gm

Desonide Cream USP 0.05% w/w packaging

Preservative Benzyl Alcohol - 2% w/w In cream Base... q.s.

  • Composition: Preservative Benzyl Alcohol - 2% w/w In cream Base... q.s....
  • Packaging: 15gm
  • Approved Use: Topical Application

Dermatological

ED-PERM 20gm

ED-PERM packaging

Betamethasone Valerate IP.. Eq. To Betamethasone - 0.1% w/w Chlorocresol IP 0.1% w/w (As Preservative)

  • Composition: Betamethasone Valerate IP.. Eq. To Betamethasone - 0.1% w/w Chlorocresol IP 0.1% w/w (As Preservativ...
  • Packaging: 20gm
  • Approved Use: Topical Application

Dermatological

EDZOLE 15gm

EDZOLE packaging

Fradiomycin Sulphate IP . : 0.5% w/w (Neomycin Sulphate IP) Cream Base : q.s

  • Composition: Fradiomycin Sulphate IP . : 0.5% w/w (Neomycin Sulphate IP) Cream Base : q.s...
  • Packaging: 15gm
  • Approved Use: Topical Application

Dermatological

FLUCONCARE 15gm

FLUCONCARE packaging

Fluocinolone acetonide IP 0.025% w/w Non-Greasy Base (Appropriate Overages added) Methyl paraben IP 0.15% w/w Propyl paraben IP 0.05% w/w (As Preservative)

  • Composition: Fluocinolone acetonide IP 0.025% w/w Non-Greasy Base (Appropriate Overages added) Methyl paraben IP ...
  • Packaging: 15gm
  • Approved Use: Topical Application

Dermatological

Fluticasone propionate cream IP 15gm

Fluticasone propionate cream IP packaging

Preservative: Potassium Sorbate & Sorbic Acid combination eq. to Sorbic Acid - 0.175% w/w In cream Base... q.s.

  • Composition: Preservative: Potassium Sorbate & Sorbic Acid combination eq. to Sorbic Acid - 0.175% w/w In cream B...
  • Packaging: 15gm
  • Approved Use: Topical Application

Dermatological

Hydrocortisone Acetate Cream IP 15gm

Hydrocortisone Acetate Cream IP packaging

  • Composition: ...
  • Packaging: 15gm
  • Approved Use: Topical Application

Dermatological

KETOMON 15gm

KETOMON packaging

Fusidic Acid IP.. Equivalent to Anhydrous Fusidic Acid-2.0% w/w Chlorocresol IP 0.1% w/w (as preservative) Cream Base.. Q.S. BP 2%w/w Beclomethasone Dipropionate, Neomycin

  • Composition: Fusidic Acid IP.. Equivalent to Anhydrous Fusidic Acid-2.0% w/w Chlorocresol IP 0.1% w/w (as preserv...
  • Packaging: 15gm
  • Approved Use: Topical Application

Dermatological

LUMON 15gm

LUMON packaging

Luliconazole IP 1% w/w Benzyl Alcohol IP 1% w/w (As preservative) Cream Base Q.S. Keep the tube tightly closed after use.

  • Composition: Luliconazole IP 1% w/w Benzyl Alcohol IP 1% w/w (As preservative) Cream Base ...
  • Packaging: 15gm
  • Approved Use: Topical Application

Dermatological

Mometasone Furoate and Fusidic Acid Cream 15gm

Mometasone Furoate and Fusidic Acid Cream packaging

Terbinafine Hydrochloride IP 1% w/w Chlorocresol IP 0.1% w/w preservative.

  • Composition: Terbinafine Hydrochloride IP 1% w/w Chlorocresol IP 0.1% w/w preservative....
  • Packaging: 15gm
  • Approved Use: Topical Application

Dermatological

MOMON 15gm

MOMON packaging

Mometasone Furoate I.P. 0.1% w/w, Cream base q.s.

  • Composition: Mometasone Furoate I.P. 0.1% w/w, Cream base q.s....
  • Packaging: 15gm
  • Approved Use: Topical Application

Dermatological

NEWMYCIN 10gm

NEWMYCIN packaging

USP 0.5%w/w Neomycin Sulphate IP : 0.5% w/w Cream Base : q.s 10 gm USP 0.5% W/W NEWMYCIN

  • Composition: USP 0.5%w/w Neomycin Sulphate IP : 0.5% w/w Cream Base : q.s 10 gm USP 0.5% W/W NEWMYCIN...
  • Packaging: 10gm
  • Approved Use: Topical Application

Dermatological

QUADERMON 5gm/15gm

QUADERMON packaging

  • Composition: ...
  • Packaging: 5gm/15gm
  • Approved Use: Topical Application

Dermatological

SILVMON 15gm

SILVMON packaging

Silver Sulphadiazine IP 1.0% w/w chlorhexidine gluconate Solution IP 2.0% w/w Cream Base. Q.S. FOR EXTERNAL USE ONLY

  • Composition: Silver Sulphadiazine IP 1.0% w/w chlorhexidine gluconate Solution ...
  • Packaging: 15gm
  • Approved Use: Topical Application

Dermatological

SILVMON PLUS 15gm

SILVMON PLUS packaging

Each Composition: Contains : Fluconazole IP 0.5% w/w Benzyl Alcohol IP 1% w/w (As preservative)

  • Composition: Each Composition: Contains : Fluconazole IP 0.5% w/w Benzyl Alcohol IP 1% w/w (As preservative)...
  • Packaging: 15gm
  • Approved Use: Topical Application

Dermatological

SOFRAMON 15gm

SOFRAMON packaging

Clobetasol Propionate IP 0.05% w/w Gentamicin Sulphate IP 0.1% w/w Eq. To Gentamicin Tolnaftate IP 1.0% w/w Iodochlorhydroxyquinoline IP 1.0% w/w Clotrimazole IP 1.0% w/w

  • Composition: Clobetasol Propionate IP 0.05% w/w Gentamicin Sulphate IP 0.1% w/w E...
  • Packaging: 15gm
  • Approved Use: Topical Application

Dermatological

Terbinafine Hydrochloride Cream IP 15gm

Terbinafine Hydrochloride Cream IP packaging

Sorbic Acid IP 0.2% w/w Butylated Hydroxytoluene IP 0.1% w/w Cream base.. O.S.

  • Composition: Sorbic Acid IP 0.2% w/w Butylated Hydroxytoluene IP 0.1% w/w Cream base.. O.S....
  • Packaging: 15gm
  • Approved Use: Topical Application

Dermatological

Tretinoin Cream USP 0.05% w/w 15gm

Tretinoin Cream USP 0.05% w/w packaging

Sorbic acid IP 0.2% w/w Butylated Hydroxytoluene IP 0.1% w/w Cream base..Q.S.

  • Composition: Sorbic acid IP 0.2% w/w Butylated Hydroxytoluene IP 0.1% w/w Cream base..Q.S....
  • Packaging: 15gm
  • Approved Use: Topical Application

Gels
Gel Form

CLIMON 20gm

CLIMON packaging

Metronidazole IP 1.0% w/w Water Soluble gel base.. Q.S.

  • Composition: Metronidazole IP 1.0% w/w Water Soluble gel base.. Q.S....
  • Packaging: 20gm
  • Approved Use: Topical Application

Gel Form

Clindamycin and Adapalene Gel 15gm

Clindamycin and Adapalene Gel packaging

Fusidic acid IP 2% w/w Cream Base

  • Composition: Fusidic acid IP 2% w/w Cream Base...
  • Packaging: 15gm
  • Approved Use: Topical Application

Gel Form

DICLOMON 30gm

DICLOMON packaging

Mometasone Furoate I.P. 0.1% w/w Cream base q.s. Mometasone Furoate Cream IP 0.1% w/w Mometasone Furoate Cream IP 0.1% w/w

  • Composition: Mometasone Furoate I.P. 0.1% w/w Cream base q.s....
  • Packaging: 30gm
  • Approved Use: Topical Application

Gel Form

EMONGEL 30gm

EMONGEL packaging

Diclofenac Diethylamine BP 1.16% w/w Eq. To Diclofenac Sodium 1% w/w Linseed Oil BP 3.0% w/w Methyl salicylate IP 10% w/w Menthol IP 0.5% w/w Capsaicin USP 0.025% w/w

  • Composition: Diclofenac Diethylamine BP 1.16% w/w Eq. To Diclofenac Sodium ...
  • Packaging: 30gm
  • Approved Use: Topical Application

Gel Form

EMONIGEL 30gm

EMONIGEL packaging

Diclofenac Diethylamine BP 1.16% w/w Eq. to Diclofenac sodium - 1% w/w Virgin Linseed Oil BP 3.0% w/w Methyl Salicylate IP 10% w/w Menthol IP 0.5% w/w

  • Composition: Diclofenac Diethylamine BP 1.16% w/w Eq. to Diclofenac sodium - 1% w/w Virgin Linseed Oil BP 3.0% w/...
  • Packaging: 30gm
  • Approved Use: Topical Application

Gel Form

FLUCOMON 15gm

FLUCOMON packaging

  • Composition: ...
  • Packaging: 15gm
  • Approved Use: Topical Application

Gel Form

LIGNOMON 2% 30gm

LIGNOMON 2% packaging

  • Composition: ...
  • Packaging: 30gm
  • Approved Use: Topical Application

Gel Form

Metronidazole Gel IP 1% W/W 15gm

Metronidazole Gel IP 1% W/W packaging

  • Composition: ...
  • Packaging: 15gm
  • Approved Use: Topical Application

Gel Form

Piroxicam Gel BP 0.5% 30gm

Piroxicam Gel BP 0.5% packaging

eq. to Clindamycin - 1% W/W Adapalene BP 0.1% w/w In a Gel Base.. Q.S.

  • Composition: eq. to Clindamycin - 1% W/W Adapalene BP 0.1% w/w In a Gel Base.. Q.S....
  • Packaging: 30gm
  • Approved Use: Topical Application

Gel Form

VOLIMON 30gm

VOLIMON packaging

Diclofenac Diethylamine BP 1.16% w/w Eq. To Diclofenac Sodium 1% w/w Virgin Linseed Oil B.P 3% w/w Methyl Salicylate IP 10 % w/w Menthol IP 5% w/w

  • Composition: Diclofenac Diethylamine BP 1.16% w/w Eq. To Diclofenac Sodium 1% w/w Virgin Linseed Oil B.P 3% w/w M...
  • Packaging: 30gm
  • Approved Use: Topical Application

Gel Form

VOLIMON H 30gm

VOLIMON H packaging

Miconazole Nitrate IP 2% w/w Cream Base.. Q.S.

  • Composition: Miconazole Nitrate IP 2% w/w Cream Base.. Q.S....
  • Packaging: 30gm
  • Approved Use: Topical Application

Ointments
Ointment

Methyl Salicylate Ointment BP 25% w/w 15gm

Methyl Salicylate Ointment BP 25% w/w packaging

Methyl Salicylate BP 25% w/w, Hydrophilic Base Q.S.

  • Composition: Methyl Salicylate BP 25% w/w, Hydrophilic Base Q.S....
  • Packaging: 15gm
  • Approved Use: Topical Application

Ointment

Povidone lodine and Ornidazole Ointment

Povidone lodine and Ornidazole Ointment packaging

Each Composition: Contains: Povidone-lodine IP 5% w/w (Availabel lodine 0.5%w/w) Ornidazole IP 1%. Ointment Base.. Q.S.

  • Composition: Each Composition: Contains: Povidone-lodine IP 5% w/w (Availabel lodine 0.5%w/w) Ornidazole IP 1%. O...
  • Packaging:
  • Approved Use: Topical Application

Ointment

POVIMON 10gm | 15gm | 20gm | 125gm | 200gm | 250gm | 500gm

POVIMON packaging

Povidone lodine IP 5% * w / w (Available lodine 0.5% * w / w ) Water soluble Ointment Base.. q.s. 20 x 10 grm Tubes 20 x 10 grm Tubes 20 x 15 grm Tubes

  • Composition: Povidone lodine IP 5% * w / w (Available lodine 0.5% * w / w ) Water soluble Ointment Base.. q.s. 20...
  • Packaging: 10gm | 15gm | 20gm | 125gm | 200gm | 250gm | 500gm
  • Approved Use: Topical Application

Ointment

Tacrolimus Ointment 0.1%w/w 15gm

Tacrolimus Ointment 0.1%w/w packaging

Fluticasone propionate IP 0.05% w/w Imidurrea IP 0.2% w/w (As Preservative) In a Non- Greasy Base

  • Composition: Fluticasone propionate IP 0.05% w/w Imidurrea IP 0.2% w/w (As Preservative) In a Non- Greasy Base...
  • Packaging: 15gm
  • Approved Use: Topical Application

Ointment

WHITMON 20gm

WHITMON packaging

  • Composition: ...
  • Packaging: 20gm
  • Approved Use: Topical Application